Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

Name: Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients
License: Public Domain

Boehringer Ingelheim

ClinicalTrials.gov · Datasets · License: Public Domain

diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 377397
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.